Search - tctmd.com

Displaying 601 - 620 of 654

Sort: Relevancy | Date

Presentation Cell Therapy 2014

Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine?

Presenter: Thomas J. Povsic

January 23, 2014

Presentation

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Presenter: P. G?n?reux

December 02, 2013

Presentation

Commercial vs. PARTNER Experience With the Transfemoral Sapien Valve for Inoperable Patients

Presenter: L.K. Pendyala

December 01, 2013

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Presentation TCT 2013

Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

Presenter: Oluseun Alli

October 29, 2013

Presentation TCT 2013

TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy

Presenter: Ajay Kirtane

October 29, 2013

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transapical TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Jean-Michel Paradis

October 29, 2013

Presentation TCT 2013

Corporate Partnerships or Development

Presenter: Mike Buck

October 28, 2013

Presentation TCT 2013

Recent Studies (Including PARTNER) Suggest That Strokes After TAVR Are Declining

Presenter: Susheel Kodali

October 28, 2013

Presentation TCT 2013

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Presenter: Eugene Blackstone

October 28, 2013

Presentation TCT 2013

PARTNER: 3 Years Later, What Have We Learned?

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Highlights of New PARTNER Results from the PARTNER Publications Office

Presenter: E. Murat Tuzcu

October 28, 2013

Presentation TCT 2013

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Physician Hospital Partnerships: Models of Success

Presenter: Robert Moss

October 28, 2013

Presentation TCT 2013

Emerging Funding Models and Partnerships: Fueling the Innovation Engine

Presenter: Casey McGlynn

October 28, 2013

Presentation TCT 2013

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

Presenter: Martin Leon

October 27, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

Advertisement

Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine?

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Commercial vs. PARTNER Experience With the Transfemoral Sapien Valve for Inoperable Patients

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transapical TAVR: A Sub-analysis from the PARTNER Trial

Corporate Partnerships or Development

Recent Studies (Including PARTNER) Suggest That Strokes After TAVR Are Declining

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

PARTNER: 3 Years Later, What Have We Learned?

Highlights of New PARTNER Results from the PARTNER Publications Office

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Physician Hospital Partnerships: Models of Success

Emerging Funding Models and Partnerships: Fueling the Innovation Engine

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content